Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Federal Trade Commission
Cantor Fitzgerald
Accenture
Daiichi Sankyo
Fuji
Novartis
Argus Health
Medtronic
QuintilesIMS

Generated: October 23, 2017

DrugPatentWatch Database Preview

Finafloxacin - Generic Drug Details

« Back to Dashboard

What are the generic sources for finafloxacin and what is the scope of finafloxacin freedom to operate?

Finafloxacin
is the generic ingredient in one branded drug marketed by Novartis Pharms Corp and is included in one NDA. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Finafloxacin has seventy-eight patent family members in thirty-five countries.

Summary for Generic Name: finafloxacin

US Patents:5
Tradenames:1
Applicants:1
NDAs:1
Bulk Api Vendors: see list10
Clinical Trials: see list7
Patent Applications: see list11
Drug Prices:see low prices
DailyMed Link:finafloxacin at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis Pharms Corp
XTORO
finafloxacin
SUSPENSION/DROPS;OTIC206307-001Dec 17, 2014RXYesYes► Subscribe► Subscribe► Subscribe
Novartis Pharms Corp
XTORO
finafloxacin
SUSPENSION/DROPS;OTIC206307-001Dec 17, 2014RXYesYes► Subscribe► SubscribeY ► Subscribe
Novartis Pharms Corp
XTORO
finafloxacin
SUSPENSION/DROPS;OTIC206307-001Dec 17, 2014RXYesYes► Subscribe► SubscribeYY ► Subscribe
Novartis Pharms Corp
XTORO
finafloxacin
SUSPENSION/DROPS;OTIC206307-001Dec 17, 2014RXYesYes► Subscribe► SubscribeYY ► Subscribe
Novartis Pharms Corp
XTORO
finafloxacin
SUSPENSION/DROPS;OTIC206307-001Dec 17, 2014RXYesYes► Subscribe► Subscribe ► Subscribe
Novartis Pharms Corp
XTORO
finafloxacin
SUSPENSION/DROPS;OTIC206307-001Dec 17, 2014RXYesYes► Subscribe► Subscribe► Subscribe
Novartis Pharms Corp
XTORO
finafloxacin
SUSPENSION/DROPS;OTIC206307-001Dec 17, 2014RXYesYes► Subscribe► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: finafloxacin

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis Pharms Corp
XTORO
finafloxacin
SUSPENSION/DROPS;OTIC206307-001Dec 17, 2014► Subscribe► Subscribe
Novartis Pharms Corp
XTORO
finafloxacin
SUSPENSION/DROPS;OTIC206307-001Dec 17, 2014► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: finafloxacin

Country Document Number Estimated Expiration
Canada2888641► Subscribe
Australia5854198► Subscribe
Poland333928► Subscribe
Estonia9900248► Subscribe
Japan4463380► Subscribe
Australia2010266120► Subscribe
Norway992903► Subscribe
Argentina077372► Subscribe
Australia717751► Subscribe
China1245428► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Julphar
Federal Trade Commission
Moodys
McKesson
Harvard Business School
Boehringer Ingelheim
Deloitte
Fuji
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot